• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发诱导线粒体生物合成用于治疗急慢性退行性疾病的疗法。

Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.

作者信息

Cameron Robert B, Beeson Craig C, Schnellmann Rick G

机构信息

Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina , 280 Calhoun Street, Charleston, South Carolina 29425, United States.

College of Pharmacy, University of Arizona , 1295 N. Martin Avenue, Tucson, Arizona 85721, United States.

出版信息

J Med Chem. 2016 Dec 8;59(23):10411-10434. doi: 10.1021/acs.jmedchem.6b00669. Epub 2016 Sep 27.

DOI:10.1021/acs.jmedchem.6b00669
PMID:27560192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5564430/
Abstract

Mitochondria have various roles in cellular metabolism and homeostasis. Because mitochondrial dysfunction is associated with many acute and chronic degenerative diseases, mitochondrial biogenesis (MB) is a therapeutic target for treating such diseases. Here, we review the role of mitochondrial dysfunction in acute and chronic degenerative diseases and the cellular signaling pathways by which MB is induced. We then review existing work describing the development and application of drugs that induce MB in vitro and in vivo. In particular, we discuss natural products and modulators of transcription factors, kinases, cyclic nucleotides, and G protein-coupled receptors.

摘要

线粒体在细胞代谢和内环境稳态中发挥着多种作用。由于线粒体功能障碍与许多急性和慢性退行性疾病相关,线粒体生物合成(MB)是治疗此类疾病的一个治疗靶点。在此,我们综述线粒体功能障碍在急性和慢性退行性疾病中的作用以及诱导MB的细胞信号通路。然后,我们综述了描述在体外和体内诱导MB的药物的开发和应用的现有研究。特别地,我们讨论了天然产物以及转录因子、激酶、环核苷酸和G蛋白偶联受体的调节剂。

相似文献

1
Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.开发诱导线粒体生物合成用于治疗急慢性退行性疾病的疗法。
J Med Chem. 2016 Dec 8;59(23):10411-10434. doi: 10.1021/acs.jmedchem.6b00669. Epub 2016 Sep 27.
2
Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic Diseases.线粒体生物发生作为药物靶点:急性和慢性疾病的新方法。
Annu Rev Pharmacol Toxicol. 2016;56:229-49. doi: 10.1146/annurev-pharmtox-010715-103155. Epub 2015 Nov 4.
3
Structural and pharmacological basis for the induction of mitochondrial biogenesis by formoterol but not clenbuterol.福莫特罗诱导线粒体生物发生而克仑特罗不诱导的结构和药理学基础。
Sci Rep. 2017 Sep 5;7(1):10578. doi: 10.1038/s41598-017-11030-5.
4
Chemoprevention of obesity by dietary natural compounds targeting mitochondrial regulation.通过靶向线粒体调节的膳食天然化合物进行肥胖的化学预防。
Mol Nutr Food Res. 2017 Jun;61(6). doi: 10.1002/mnfr.201600721. Epub 2016 Dec 30.
5
Serotonin regulation of mitochondria in kidney diseases.血清素对肾脏疾病中线粒体的调节作用。
Pharmacol Res. 2024 May;203:107154. doi: 10.1016/j.phrs.2024.107154. Epub 2024 Mar 22.
6
Curcumin, mitochondrial biogenesis, and mitophagy: Exploring recent data and indicating future needs.姜黄素、线粒体生物发生和线粒体自噬:探索最新数据并指出未来需求。
Biotechnol Adv. 2016 Sep-Oct;34(5):813-826. doi: 10.1016/j.biotechadv.2016.04.004. Epub 2016 May 1.
7
Activation of TGR5 promotes mitochondrial biogenesis in human aortic endothelial cells.TGR5 的激活促进人主动脉内皮细胞中线粒体生物发生。
Biochem Biophys Res Commun. 2018 Jun 12;500(4):952-957. doi: 10.1016/j.bbrc.2018.04.210. Epub 2018 May 2.
8
A High-Throughput Screening of a Natural Products Library for Mitochondria Modulators.天然产物文库中用于线粒体调节剂的高通量筛选
Biomolecules. 2024 Apr 4;14(4):440. doi: 10.3390/biom14040440.
9
Dynamic comparisons of high-resolution expression profiles highlighting mitochondria-related genes between in vivo and in vitro fertilized early mouse embryos.体内和体外受精的早期小鼠胚胎之间线粒体相关基因的高分辨率表达谱动态比较。
Hum Reprod. 2015 Dec;30(12):2892-911. doi: 10.1093/humrep/dev228. Epub 2015 Sep 18.
10
Mitochondria: A Novel Therapeutic Target in Diabetic Nephropathy.线粒体:糖尿病肾病中的一个新型治疗靶点。
Curr Med Chem. 2017;24(29):3185-3202. doi: 10.2174/0929867324666170509121003.

引用本文的文献

1
Discovery of a Novel, Potent, and Selective 5‑Hydroxytryptamine 2B Receptor Antagonist that Induces Mitochondrial Biogenesis in the Kidney.发现一种新型、强效且选择性的5-羟色胺2B受体拮抗剂,其可诱导肾脏中的线粒体生物合成。
ACS Pharmacol Transl Sci. 2025 May 30;8(6):1741-1755. doi: 10.1021/acsptsci.5c00161. eCollection 2025 Jun 13.
2
Lasmiditan induces mitochondrial biogenesis in primary mouse renal peritubular endothelial cells and augments wound healing and tubular network formation.拉米地坦可诱导原代小鼠肾周管内皮细胞的线粒体生物合成,并增强伤口愈合和肾小管网络形成。
Am J Physiol Cell Physiol. 2025 Apr 1;328(4):C1318-C1332. doi: 10.1152/ajpcell.00116.2025. Epub 2025 Mar 13.
3

本文引用的文献

1
Mitochondrial Epigenetic Changes Link to Increased Diabetes Risk and Early-Stage Prediabetes Indicator.线粒体表观遗传变化与糖尿病风险增加及早期糖尿病前期指标相关。
Oxid Med Cell Longev. 2016;2016:5290638. doi: 10.1155/2016/5290638. Epub 2016 May 19.
2
Mitochondrial dysfunction and oxidative stress in patients with chronic kidney disease.慢性肾脏病患者的线粒体功能障碍与氧化应激
Physiol Rep. 2016 May;4(9). doi: 10.14814/phy2.12780.
3
Resveratrol attenuates oxidative stress in mitochondrial Complex I deficiency: Involvement of SIRT3.
Mitochondrial quality control: a pathophysiological mechanism and potential therapeutic target for chronic obstructive pulmonary disease.
线粒体质量控制:慢性阻塞性肺疾病的一种病理生理机制及潜在治疗靶点
Front Pharmacol. 2025 Jan 3;15:1474310. doi: 10.3389/fphar.2024.1474310. eCollection 2024.
4
Mitochondrial diseases: from molecular mechanisms to therapeutic advances.线粒体疾病:从分子机制到治疗进展
Signal Transduct Target Ther. 2025 Jan 10;10(1):9. doi: 10.1038/s41392-024-02044-3.
5
Mitochondrial-targeted therapies in traumatic brain injury: From bench to bedside.创伤性脑损伤的线粒体靶向治疗:从实验台到病床边
Neurotherapeutics. 2025 Jan;22(1):e00515. doi: 10.1016/j.neurot.2024.e00515. Epub 2024 Dec 24.
6
Mitochondria in Retinal Ganglion Cells: Unraveling the Metabolic Nexus and Oxidative Stress.视网膜神经节细胞中的线粒体:揭开代谢关联和氧化应激之谜。
Int J Mol Sci. 2024 Aug 7;25(16):8626. doi: 10.3390/ijms25168626.
7
Diabetes cardiomyopathy: targeted regulation of mitochondrial dysfunction and therapeutic potential of plant secondary metabolites.糖尿病心肌病:线粒体功能障碍的靶向调控及植物次生代谢产物的治疗潜力
Front Pharmacol. 2024 Jul 9;15:1401961. doi: 10.3389/fphar.2024.1401961. eCollection 2024.
8
5-HT receptor agonism induces mitochondrial biogenesis and increases cellular function in brain microvascular endothelial cells.5-羟色胺受体激动作用可诱导线粒体生物合成,并增强脑微血管内皮细胞的细胞功能。
Front Cell Neurosci. 2024 Mar 5;18:1365158. doi: 10.3389/fncel.2024.1365158. eCollection 2024.
9
Clinically Actionable Topical Strategies for Addressing the Hallmarks of Skin Aging: A Primer for Aesthetic Medicine Practitioners.应对皮肤衰老特征的临床可行局部治疗策略:美容医学从业者入门指南
Cureus. 2024 Jan 19;16(1):e52548. doi: 10.7759/cureus.52548. eCollection 2024 Jan.
10
Boosting Mitochondrial Biogenesis Diminishes Foam Cell Formation in the Post-Stroke Brain.促进线粒体生物发生可减少中风后脑内泡沫细胞的形成。
Int J Mol Sci. 2023 Nov 23;24(23):16632. doi: 10.3390/ijms242316632.
白藜芦醇减轻线粒体复合体I缺乏症中的氧化应激:沉默调节蛋白3的作用
Free Radic Biol Med. 2016 Jul;96:190-8. doi: 10.1016/j.freeradbiomed.2016.04.027. Epub 2016 Apr 25.
4
The fine tuning of metabolism, autophagy and differentiation during in vitro myogenesis.体外成肌过程中新陈代谢、自噬和分化的精细调节。
Cell Death Dis. 2016 Mar 31;7(3):e2168. doi: 10.1038/cddis.2016.50.
5
Curcumin Rescues a PINK1 Knock Down SH-SY5Y Cellular Model of Parkinson's Disease from Mitochondrial Dysfunction and Cell Death.姜黄素挽救 PINK1 敲低 SH-SY5Y 帕金森病细胞模型的线粒体功能障碍和细胞死亡。
Mol Neurobiol. 2017 May;54(4):2752-2762. doi: 10.1007/s12035-016-9843-0. Epub 2016 Mar 22.
6
(-)-Epicatechin-induced recovery of mitochondria from simulated diabetes: Potential role of endothelial nitric oxide synthase.(-)-表儿茶素诱导模拟糖尿病状态下线粒体的恢复:内皮型一氧化氮合酶的潜在作用
Diab Vasc Dis Res. 2016 May;13(3):201-10. doi: 10.1177/1479164115620982. Epub 2016 Mar 18.
7
Neonatal SSRI exposure improves mitochondrial function and antioxidant defense in rat heart.新生儿暴露于选择性5-羟色胺再摄取抑制剂可改善大鼠心脏的线粒体功能和抗氧化防御能力。
Appl Physiol Nutr Metab. 2016 Apr;41(4):362-9. doi: 10.1139/apnm-2015-0494. Epub 2015 Nov 24.
8
Application of an Integrated GPCR SAR-Modeling Platform To Explain the Activation Selectivity of Human 5-HT2C over 5-HT2B.应用整合的GPCR SAR建模平台解释人5-HT2C相对于5-HT2B的激活选择性
ACS Chem Biol. 2016 May 20;11(5):1372-82. doi: 10.1021/acschembio.5b01045. Epub 2016 Mar 7.
9
Mitochondrial redox status as a target for cardiovascular disease.线粒体氧化还原状态作为心血管疾病的一个靶点。
Curr Opin Pharmacol. 2016 Apr;27:50-5. doi: 10.1016/j.coph.2016.01.006. Epub 2016 Feb 16.
10
Deficiency in Apoptosis-Inducing Factor Recapitulates Chronic Kidney Disease via Aberrant Mitochondrial Homeostasis.凋亡诱导因子缺乏通过异常的线粒体稳态再现慢性肾脏病。
Diabetes. 2016 Apr;65(4):1085-98. doi: 10.2337/db15-0864. Epub 2016 Jan 28.